Influenza Vaccine
Influenza Vaccine is a biological therapy with 94 clinical trials. Currently 6 active trials ongoing. Historical success rate of 88.3%.
Success Metrics
Based on 68 completed trials
Phase Distribution
Phase Distribution
8
Early Stage
21
Mid Stage
33
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
88.3%
68 of 77 finished
11.7%
9 ended early
6
trials recruiting
94
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae
Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE
Influenza Vaccination After Acute Coronary Syndrome
Immunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines in Adults
Beta-glucan and Immune Response to Influenza Vaccine
Clinical Trials (94)
Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae
Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE
Influenza Vaccination After Acute Coronary Syndrome
Immunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines in Adults
Beta-glucan and Immune Response to Influenza Vaccine
A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age
Covid-19 and Influenza Oral Vaccine Study
Immune Responses in Health Care Personnel
HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia
Determining the Relationship Between Gut Microbiota and Immune Response to Influenza or COVID-19 Vaccine
A Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target Population
A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age
VSMART (Video-Conference Stress Management and Relaxation Training for Older Women With Breast Cancer)
A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults
Influenza Vaccine Responses as a Means of Assessing Immune Competence in Chimeric Kidney/Stem Cell Transplant Recipients
Influenza Vaccine Elicited Immune Response in Immunocompromised Patients
Maternal Determinants of Immunity to Influenza
Agaricus Bisporus and Influenza Vaccination Response
Analysis of Antigen Specific B Cell Responses to Immunization With Influenza Virus Vaccine
Body and Social Behavior
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 94